Article

Pfizer to disclose payment of health-care professionals

Pfizer will disclose publicly its compensation of U.S. health-care professionals for consulting, speaking engagements, and clinical trials by early next year on the company's Web site.

Key Points

New York-Pfizer will disclose publicly its compensation of U.S. health-care professionals for consulting, speaking engagements, and clinical trials by early next year on the company's Web site, according to a prepared statement from the company.

The disclosures will include payments made to practicing U.S. physicians and other health-care providers, principal investigators, major academic institutions, and research sites for clinical trials sponsored by the company. According to the statement, Pfizer is sharing this information to provide greater clarity and understanding of the valuable scientific innovations and improved patient care that result from collaborations with health-care professionals, as well as to reflect the spirit of the recent proposed legislation by the Pharmaceutical Research and Manufacturers of America regarding payments to physicians.

"Pfizer has made an important step forward with this extensive disclosure policy. The release of financial information about consulting, education, and clinical research activities sets a standard for transparency in the pharmaceutical and medical device industries," said Andrew F. Leuchter, MD, professor of psychiatry and biobehavioral sciences and associate dean of the David Geffen School of Medicine at the University of California, Los Angeles. "I believe policies such as these will help restore public confidence in the relationships physicians and academic medical centers have with the industry."

This effort makes Pfizer the first biopharmaceutical company to commit to reporting payments for conducting phase I to IV clinical trials in addition to disclosing payments for speaking and consulting, according to the statement.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.